New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing medicines.
This isn’t an on/off switch we can flip. We can, instead, determine if metastasis is “turned on” allowing us to much, much, better predict malignancy and what treatment regimen to use.
For those not reading the article
This isn’t an on/off switch we can flip. We can, instead, determine if metastasis is “turned on” allowing us to much, much, better predict malignancy and what treatment regimen to use.